KR102313188B1 - Honey Composition comprising Ganoderma Lucidum and Manufacturing Method thereof - Google Patents
Honey Composition comprising Ganoderma Lucidum and Manufacturing Method thereof Download PDFInfo
- Publication number
- KR102313188B1 KR102313188B1 KR1020210008167A KR20210008167A KR102313188B1 KR 102313188 B1 KR102313188 B1 KR 102313188B1 KR 1020210008167 A KR1020210008167 A KR 1020210008167A KR 20210008167 A KR20210008167 A KR 20210008167A KR 102313188 B1 KR102313188 B1 KR 102313188B1
- Authority
- KR
- South Korea
- Prior art keywords
- reishi mushroom
- mixed powder
- weight
- parts
- reishi
- Prior art date
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 134
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 134
- 235000012907 honey Nutrition 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 239000011812 mixed powder Substances 0.000 claims abstract description 68
- 238000000034 method Methods 0.000 claims abstract description 48
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 131
- 210000002969 egg yolk Anatomy 0.000 claims description 55
- 102000002322 Egg Proteins Human genes 0.000 claims description 44
- 108010000912 Egg Proteins Proteins 0.000 claims description 44
- 235000013345 egg yolk Nutrition 0.000 claims description 44
- 238000000576 coating method Methods 0.000 claims description 43
- 239000003607 modifier Substances 0.000 claims description 40
- 239000000843 powder Substances 0.000 claims description 36
- 239000011248 coating agent Substances 0.000 claims description 31
- 241000237858 Gastropoda Species 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 22
- 238000004108 freeze drying Methods 0.000 claims description 21
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 10
- 240000006891 Artemisia vulgaris Species 0.000 claims description 10
- 235000015701 Artemisia arbuscula Nutrition 0.000 claims description 8
- 235000002657 Artemisia tridentata Nutrition 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 8
- 241000332371 Abutilon x hybridum Species 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 7
- 244000187129 Bacopa monnieria Species 0.000 claims description 7
- 235000015418 Bacopa monnieria Nutrition 0.000 claims description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 7
- 235000008434 ginseng Nutrition 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 235000017788 Cydonia oblonga Nutrition 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 239000011363 dried mixture Substances 0.000 claims description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims 2
- 235000003097 Artemisia absinthium Nutrition 0.000 claims 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims 2
- 239000001138 artemisia absinthium Substances 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract 2
- 244000010000 Hovenia dulcis Species 0.000 abstract 2
- 241000254099 Melolontha melolontha Species 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- 239000004480 active ingredient Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 20
- 229930182735 Ganoderic acid Natural products 0.000 description 19
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 238000000605 extraction Methods 0.000 description 17
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 16
- 239000002245 particle Substances 0.000 description 16
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 16
- 230000008569 process Effects 0.000 description 15
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 15
- 230000002776 aggregation Effects 0.000 description 14
- 238000002203 pretreatment Methods 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 12
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 12
- 229960002061 ergocalciferol Drugs 0.000 description 12
- 238000005507 spraying Methods 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 12
- 235000001892 vitamin D2 Nutrition 0.000 description 12
- 239000011653 vitamin D2 Substances 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 11
- 238000004220 aggregation Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 238000003809 water extraction Methods 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 238000000227 grinding Methods 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 240000003291 Armoracia rusticana Species 0.000 description 8
- 235000011330 Armoracia rusticana Nutrition 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 238000002481 ethanol extraction Methods 0.000 description 8
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000007654 immersion Methods 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000000787 lecithin Substances 0.000 description 6
- 235000010445 lecithin Nutrition 0.000 description 6
- 229940067606 lecithin Drugs 0.000 description 6
- 235000021096 natural sweeteners Nutrition 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 238000004080 punching Methods 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- 206010061549 Sensation of foreign body Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 210000001534 vitelline membrane Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960002737 fructose Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- -1 honey Chemical class 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 235000019534 high fructose corn syrup Nutrition 0.000 description 2
- 238000007602 hot air drying Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000252132 Pleurotus eryngii Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940124594 traditional oriental medicine Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 영지버섯을 포함하는 꿀 조성물 및 이의 제조방법에 관한 것으로서, 보다 상세하게는 영지버섯, 헛개, 굼벵이를 포함하는 혼합분말을 포함하는 꿀 조성물 및 이의 제조방법에 관한 것이다.The present invention relates to a honey composition containing reishi mushroom and a method for preparing the same, and more particularly, to a honey composition comprising a mixed powder containing reishi mushroom, hutgae, and slugs, and a method for preparing the same.
영지버섯(Ganoderma lucidum Karsten)은 불로초과에 속하는 버섯으로 반원, 콩팥, 부채 모양이며, 편평하고 동심형의 고리 모양 홈이 존재하며, 갓과 자루의 표면에는 옻칠을 한 것과 같은 광택이 있고, 촉감은 딱딱하다.Ganoderma lucidum Karsten (Ganoderma lucidum Karsten) is a mushroom belonging to the family Blossomaceae. It has semicircle, kidney, and fan-shaped, flat and concentric ring-shaped grooves. It's hard.
영지버섯의 생리활성 물질로는 트리테르페노이드류, 스테로이드류, 헥산류, 글리칸류, 게르마늄, 렉틴, 항트롬빈 성분 등을 포함하고 있으며, 영지버섯은 면역증강, 콜레스테롤 제거, 혈전방지, 간염치료, 항암, 항발암, 혈당감소, 원기회복 등 다양한 효과를 가진 것으로 밝혀져 있다. The physiologically active substances of reishi mushroom include triterpenoids, steroids, hexanes, glycans, germanium, lectin, and antithrombin components. It has been found to have various effects such as anti-cancer, anti-cancer, blood sugar reduction, and rejuvenation.
영지버섯의 생리활성 물질 중 가노데릭산(ganoderic acid)은 영지버섯에만 존재하는 고유성분으로, 상기 가노데릭산은 면역 기능 증진에 탁월하며, 그외 항염, 항산화, 항당뇨, 항비만 등의 효과가 우수하다. 특히, 아토피·건선 등 피부염증을 완화 및 예방하고, 콜레스테롤 수치를 낮추며, 폐암, 백혈병 및 기타 암 치료에 효과적인 것으로 알려져 있다.Among the physiologically active substances of reishi mushroom, ganoderic acid is a unique component that exists only in reishi mushroom, and the ganoderic acid is excellent in enhancing immune function, and other effects such as anti-inflammatory, antioxidant, anti-diabetic and anti-obesity are excellent. do. In particular, it is known to be effective in alleviating and preventing skin inflammation such as atopic dermatitis and psoriasis, lowering cholesterol levels, and treating lung cancer, leukemia and other cancers.
이처럼 영지버섯은 다양한 유효성분을 포함하며, 다양한 식품 및 건강기능식품에 적용되어 왔다. 식품류에 영지버섯을 이용한 특허문헌으로, 국내등록특허 제10-1197679호에서 영지버섯과 두충, 황정, 사삼, 우슬을 분말화하고 끓여 영지버섯물질을 형성하고, 이를 커피와 혼합한 영지버섯커피를 제시하고 있다. As such, reishi mushroom contains various active ingredients and has been applied to various foods and health functional foods. As a patent document using reishi mushroom in foods, in domestic registration patent No. 10-1197679, reishi mushroom, duchung, hwangjeong, ginseng, and hyssop are powdered and boiled to form a reishi mushroom substance, and reishi mushroom coffee is mixed with coffee. is presenting
또한, 국내등록특허 제10-2182076호에서는 영지버섯, 영지버섯, 새송이버섯을 열수추출-가열하는 공정을 수회 수행하여 버섯추출물을 제조하고, 탈지분유 및 프락토올리고당을 첨가한 후 유산균 균주를 접종하여 배양 및 숙성한 버섯자실체 추출물을 함유한 유산균 배지 조성물, 이를 이용한 유산균 발효조성물 및 이의 제조방법을 제시하고 있다.In addition, in Korean Patent Registration No. 10-2182076, the process of hot water extraction-heating of reishi mushroom, reishi mushroom, and king oyster mushroom is performed several times to prepare a mushroom extract, and after adding skim milk powder and fructooligosaccharide, the lactic acid bacteria strain is inoculated. A lactic acid bacterium medium composition containing an extract of cultured and matured mushroom fruiting body, a lactic acid bacterium fermented composition using the same, and a manufacturing method thereof are presented.
영지버섯은 고유의 딱딱한 질감 때문에 섭취하기가 용이하지 않았으며, 상기 특허문헌과 같이 열수추출 등의 용매추출을 통해 액상으로 섭취되거나, 건조 및 분말화를 통해 섭취되어 왔다.Reishi mushroom was not easy to ingest because of its inherent hard texture, and has been ingested in liquid form through solvent extraction such as hot water extraction as in the above patent document, or ingested through drying and powdering.
하지만, 가노데릭산 등의 대부분 유효성분은 열수추출을 통해 쉽게 용출되지 않으며, 고온에서는 유효성분의 변성이 발생되기 때문에 영지버섯으로부터 유효성분을 수득하는 것이 용이하지 않았다. However, most active ingredients such as ganoderic acid are not easily eluted through hot water extraction, and it was not easy to obtain active ingredients from Reishi mushroom because denaturation of the active ingredients occurs at high temperatures.
또한, 영지버섯 추출물은 고미성분을 포함하여 기호도가 낮아 꿀 등의 당류와 함께 배합하여 섭취하고자 하는 시도가 있었으나, 액상의 영지버섯 추출물은 변성의 우려가 있으며, 분말상의 영지버섯 추출물은 균일한 분산이 어려워 응집현상이 발생되는 문제점이 있었다.In addition, the reishi mushroom extract contains bitter ingredients and has low taste, so an attempt has been made to mix it with sugars such as honey, but there is a risk of denaturation of the liquid reishi mushroom extract, and the powdered reishi mushroom extract is uniformly dispersed This was difficult, and there was a problem that agglomeration phenomenon occurred.
상기와 같은 문제점을 해결하기 위한 본 발명의 목적은 영지버섯의 유효성분의 추출을 극대화하고, 헛개와 굼벵이를 포함하여 영양학적 가치를 더욱 높이며, 당류 베이스에서 균일한 분산이 가능한 영지버섯을 포함하는 꿀 조성물 및 이의 제조방법을 제공하는 것이다.An object of the present invention to solve the above problems is to maximize the extraction of the active ingredient of reishi mushroom, to further increase the nutritional value, including horseradish and slug, and to include reishi mushroom that can be uniformly dispersed in the sugar base. It is to provide a honey composition and a method for preparing the same.
상기 과제를 해결하기 위한 본 발명의 영지버섯을 포함하는 꿀 조성물은 꿀에 영지버섯, 헛개, 굼벵이를 포함하는 혼합분말을 혼합한 것을 특징으로 한다. Honey composition comprising reishi mushroom of the present invention for solving the above problem is characterized in that the honey is mixed with a mixed powder containing reishi mushroom, hutgae, and slugs.
상기 혼합분말은 영지버섯 100중량부에 대하여 헛개 1 내지 5 중량부, 굼벵이 0.1 내지 3 중량부를 포함한다.The mixed powder includes 1 to 5 parts by weight of hutgae and 0.1 to 3 parts by weight of slugs based on 100 parts by weight of reishi mushroom.
상기 영지버섯을 포함하는 꿀 조성물은 꿀 100 중량부에 대하여 혼합분말 0.1 내지 30중량부를 포함한다.The honey composition containing the reishi mushroom contains 0.1 to 30 parts by weight of mixed powder based on 100 parts by weight of honey.
상기 과제를 해결하기 위한 본 발명의 영지버섯을 포함하는 꿀 조성물의 제조방법은 영지버섯, 헛개, 굼벵이를 포함하는 혼합분말을 제조하는 혼합분말 제조단계(S100);와 상기 혼합분말과 꿀을 혼합하는 혼합단계(S200);를 포함한다.The method for producing a honey composition containing reishi mushroom of the present invention for solving the above problems is a mixed powder manufacturing step (S100) of preparing a mixed powder containing reishi mushroom, sagebrush, and slugs; and mixing the mixed powder and honey and a mixing step (S200).
상기 혼합분말 제조단계(S100)는 영지버섯 100중량부에 대하여 헛개 1 내지 5 중량부, 굼벵이 0.1 내지 3 중량부를 포함한다.The mixed powder manufacturing step (S100) includes 1 to 5 parts by weight of sagebrush and 0.1 to 3 parts by weight of slugs based on 100 parts by weight of reishi mushroom.
상기 혼합단계(S200)는 꿀 100 중량부에 대하여 혼합분말 0.1 내지 30중량부를 혼합한다.In the mixing step (S200), 0.1 to 30 parts by weight of the mixed powder is mixed with respect to 100 parts by weight of honey.
상술한 바와 같이, 본 발명에 따른 영지버섯을 포함하는 꿀 조성물 및 이의 제조방법에 의하면, 영지버섯의 유효성분의 추출을 극대화하고, 헛개와 굼벵이를 포함하여 영양학적 가치를 더욱 높이며, 당류 베이스에서 균일한 분산이 가능한 효과가 있다.As described above, according to the honey composition containing reishi mushroom and its manufacturing method according to the present invention, the extraction of the active ingredient of the reishi mushroom is maximized, the nutritional value is further increased, including the sagebrush and slug, and in the sugar base. It has the effect that uniform dispersion is possible.
본 발명의 구체적 특징 및 이점들은 이하에서 첨부도면을 참조하여 상세히 설명한다. 이에 앞서 본 발명에 관련된 기능 및 그 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우에는 구체적인 설명을 생략하기로 한다.Specific features and advantages of the present invention will be described in detail below with reference to the accompanying drawings. Prior to this, if it is determined that the detailed description of the function and its configuration related to the present invention may unnecessarily obscure the gist of the present invention, the detailed description will be omitted.
본 발명은 영지버섯을 포함하는 꿀 조성물 및 이의 제조방법에 관한 것으로서, 보다 상세하게는 영지버섯, 헛개, 굼벵이를 포함하는 혼합분말을 포함하는 꿀 조성물 및 이의 제조방법에 관한 것이다.The present invention relates to a honey composition containing reishi mushroom and a method for preparing the same, and more particularly, to a honey composition comprising a mixed powder containing reishi mushroom, hutgae, and slugs, and a method for preparing the same.
본 발명의 사용된 원료 '굼벵이'는 동의보감 등 전통 한방의서에 간암, 간경화 등 간 질환을 비롯해 시력감퇴, 백내장, 중풍 등 성인병 치료에 효과가 있다고 기록돼 있으며, 굼벵이에 포함된 '인돌 알칼로이드'라는 물질이 혈전의 치유와 혈액순환 개선에 큰 효능이 있다. The raw material 'slugi' used in the present invention is recorded in traditional oriental medicine books such as Donguibogam to be effective in treating liver diseases such as liver cancer and cirrhosis, as well as adult diseases such as macular degeneration, cataracts, and stroke. This substance has a great effect on the healing of blood clots and improvement of blood circulation.
또한, 굼벵이의 주성분인 프로테신은 천연항생단백질로 간의 해독, 간세포 보호효과가 우수하며, 불포화지방산과 니아신 성분은 혈중 콜레스테롤 수치를 떨어뜨리며, 심혈관 질환에 예방에 효과적이다.In addition, protecin, the main component of slugs, is a natural antibiotic protein and has excellent liver detoxification and hepatocellular protection effects.
또한 단백질이 풍부한 고단백 물질이고, 비타민 B가 풍부하게 포함되어 있어 피로회복에 도움을 준다.In addition, it is a high-protein substance rich in protein and contains abundant vitamin B, which helps to recover from fatigue.
본 발명의 사용된 원료 '헛개(나무)'는 갈매나무과의 낙엽교목으로 '지구자'로 지칭되기도 하며, 깊은 산이나 고지의 양지에 주로 서식한다.The raw material 'heotgae (tree)' used in the present invention is a deciduous tree of the buckthorn family, also referred to as 'jigja', and mainly inhabits in the sun in deep mountains or highlands.
헛개는 뿌리, 잎, 껍질, 줄기, 열매 모두가 약용을 사용가능하며, 헛개의 암페롭신과 호베니틴스는 손상된 간세포를 회복 시켜주고 손상될 수 있는 간을 보호해주는 효능이 있어 숙취해소에 탁월한 효과가 있다.The roots, leaves, bark, stems, and fruits of hutgae can be used medicinally, and the ampheropsin and hobenitins of hutches have the effect of restoring damaged liver cells and protecting the liver, which is an excellent effect in relieving a hangover. there is
또한, 헛개가 포함하는 칼슘을 비롯한 후랑구라닌, 호베닌, 호베느시드, 하벤산은 피로회복, 구토증 치료효과가 있으며, 더불어 항염, 진통완화, 붓기제거, 노폐물 배출촉진 등의 효과를 갖는다.In addition, furanguranin, hobenin, hobenecid, and habenic acid, including calcium, contained in hutgae have effects of recovery from fatigue and treatment of vomiting, and also have effects such as anti-inflammatory, pain relief, swelling removal, and promotion of waste discharge.
본 발명에 따른 영지버섯을 포함하는 꿀 조성물의 제조방법은 영지버섯, 헛개, 굼벵이를 포함하는 혼합분말을 제조하는 혼합분말 제조단계(S100)와 상기 혼합분말과 꿀을 혼합하는 혼합단계(S200)를 포함한다.The method for producing a honey composition comprising reishi mushroom according to the present invention includes a mixed powder manufacturing step (S100) of preparing a mixed powder containing reishi mushroom, sagebrush, and slugs, and a mixing step of mixing the mixed powder and honey (S200) includes
혼합분말 제조단계(S100)에서는 영지버섯, 헛개, 굼벵이를 포함하는 혼합분말을 제조하는 단계로, 제 1실시예에 따른 혼합분말 제조단계(S100)는 영지버섯 100중량부에 대하여 헛개 1 내지 5 중량부, 굼벵이 0.1 내지 3 중량부를 혼합한 분말을 제조하는 단계로, 혼합분말은 영지버섯분말, 헛개분말, 굼벵이 분말을 혼합하거나, 원물 또는 건조된 상태의 원료를 모두 배합한 후 분말화할 수 있다.The mixed powder manufacturing step (S100) is a step of preparing a mixed powder containing reishi mushroom, sagebrush, and slugs, and the mixed powder manufacturing step (S100) according to the first embodiment is 1 to 5 hutgae with respect to 100 parts by weight of reishi mushroom. In a step of preparing a powder in which parts by weight, 0.1 to 3 parts by weight of slugs are mixed, the mixed powder can be powdered after mixing reishi mushroom powder, horseradish powder, slug powder, or all raw materials or raw materials in a dried state. .
또한, 혼합분말은 영지버섯 100중량부에 대하여 새싹보리 0.1 내지 3중량부, 솔잎 0.5 내지 5 중량부를 추가로 더 포함하는 것도 가능하다.In addition, the mixed powder may further include 0.1 to 3 parts by weight of barley sprouts and 0.5 to 5 parts by weight of pine needles based on 100 parts by weight of reishi mushroom.
분말화방법은 열풍건조, 동결건조 또는 이들의 조합 중 어느 하나의 건조방법을 이용할 수 있으며, 바람직하게는, 유효성분의 변성을 최소화할 수 있는 동결건조법을 이용할 수 있다.For the powdering method, any one of hot air drying, freeze drying, or a combination thereof may be used, and preferably, a freeze drying method capable of minimizing denaturation of the active ingredient may be used.
동결건조시 동결온도는 -60 내지 -40℃ 에서 수행될 수 있으며, 진공도는 동결된 얼음입자가 승화되는 진공범위이면 특별히 제약받지 않으나 통상 0.5 내지 5 torr로 제어될 수 있다. 동결건조 후에 평균입경 50 내지 500 ㎛를 갖도록 분쇄처리할 수 있다.During freeze-drying, the freezing temperature can be carried out at -60 to -40°C, and the degree of vacuum is not particularly limited as long as the vacuum range is in which the frozen ice particles are sublimed, but can be controlled to usually 0.5 to 5 torr. After freeze-drying, it may be pulverized to have an average particle diameter of 50 to 500 μm.
영지버섯은 자실체, 균사체 또는 이들의 조합 중 어느 하나를 사용할 수 있으며, 유효성분 추출특성을 향상시키기 위한 영지버섯 전처리단계를 통해 전처리될 수 있다.Reishi mushroom may use any one of fruiting body, mycelium, or a combination thereof, and may be pre-treated through a reishi mushroom pre-treatment step to improve the extraction characteristics of active ingredients.
영지버섯 전처리단계에서는 고압풍 또는 고압수를 이용하여 표면의 이물질 및 포자를 제거하는 1차 단계와 이물질이 제거된 영지버섯의 표면에 체크 무늬의 칼집을 내거나 평균직경 0.1 내지 3mm의 미세 바늘로 단위면적(㎠)당 타공수 3 내지 100이 되도록 펀칭처리하는 2차 단계를 포함할 수 있다.In the pre-treatment step of reishi mushroom, the first step is to remove foreign substances and spores on the surface using high-pressure wind or high-pressure water, and a checkered cut is made on the surface of the reishi mushroom from which foreign substances have been removed, or a fine needle with an average diameter of 0.1 to 3 mm is used. It may include a secondary step of punching so that the number of perforations per area (cm 2 ) is 3 to 100.
2차 단계에서는 영지버섯을 평균입경 5 내지 15 mm 로 조쇄하는 것도 가능하나, 조쇄공정을 통해 영지버섯 유효성분의 산화가 발생될 수 있기 때문에 영지버섯의 가공 표면적을 지나치게 증가시키지 않도록 칼집을 내거나 펀칭하는 것이 바람직하다.In the second step, it is possible to crush the reishi mushroom to an average particle diameter of 5 to 15 mm, but since oxidation of the active ingredient of the reishi mushroom may occur through the crushing process, cut or punch the reishi mushroom to avoid excessively increasing the processed surface area of the mushroom. It is preferable to do
또한, 상기 영지버섯 전처리단계는 1차 단계 또는 2차 단계 이후, 스팀처리단계 및 자외선 조사단계를 수행할 수 있다.In addition, the pre-treatment step of reishi mushroom may be performed after the first step or the second step, the steam treatment step and the ultraviolet irradiation step.
스팀처리는 물이 끓기시작하면 스팀기에 영지버섯을 투입하여 3 내지 5분간 수행될 수 있으며, 이때, 물 대신에 5 내지 15vol % 의 에탄올 수용액을 이용하는 것도 가능하다. Steam treatment can be performed for 3 to 5 minutes by putting the reishi mushroom in the steamer when the water starts to boil. At this time, it is also possible to use an aqueous solution of 5 to 15 vol % of ethanol instead of water.
자외선 조사단계는 영지버섯 내의 비타민 D2의 전구체인 에르고스테롤(ergosterol)을 비타민 D2 인 에르고칼시페롤(ergocalciferol)로 전환시키고, 잔여하는 미생물 및 오염물질을 제거하기 위한 단계로, 자외선 조사 영역대는 280-320nm의 파장영역대(UV-B)를 이용할 수 있으며, 자외선 조사시간은 5 내지 30분간 수행될 수 있다.The UV irradiation step is a step for converting ergosterol, a precursor of vitamin D 2 in Reishi mushroom, to ergocalciferol, which is vitamin D 2 , and removing residual microorganisms and contaminants. The band may use a wavelength band (UV-B) of 280-320 nm, and UV irradiation time may be performed for 5 to 30 minutes.
이때, 자외선 조사처리를 처리하기에 앞서 스팀처리를 수행하는 것이 바람직한데, 스팀처리를 통해 영지버섯 조직의 내물질 순환 및 반응성을 증가시킴으로써 자외선 조사에 따른 전환반응이 증대될 수 있다.At this time, it is preferable to perform a steam treatment prior to the UV irradiation treatment. By increasing the internal material circulation and reactivity of the reishi mushroom tissue through the steam treatment, the conversion reaction according to the UV irradiation can be increased.
보다 바람직하게는, 영지버섯 전처리 단계는 1차 단계-2차 단계-스팀처리단계- 자외선 조사단계를 순차적으로 진행할 수 있다.More preferably, the pre-treatment step of reishi mushroom may proceed sequentially from the first step - the second step - the steam treatment step - the ultraviolet irradiation step.
제 2실시예에 따른 혼합분말 제조단계(S100)는 영지버섯의 건조, 분말화 등의 가공공정에서 발생되는 유효성분의 변성 및 소실을 방지하기 위하여 영지버섯을 난황액에 처리하는 공정을 포함하는 것으로, 영지버섯에 난황액을 도포하는 난황액 도포단계와 난황액이 도포된 영지버섯과 헛개, 굼벵이를 동결건조하는 동결건조단계와 동결건조된 혼합물을 분쇄하는 분말화단계를 포함하는 것을 특징으로 한다.The mixing powder manufacturing step (S100) according to the second embodiment includes a process of treating the reishi mushroom in egg yolk solution in order to prevent denaturation and loss of the active ingredient generated in the processing process such as drying and powdering of the reishi mushroom. It is characterized in that it comprises an egg yolk liquid application step of applying egg yolk liquid to the reishi mushroom, a freeze-drying step of freeze-drying the reishi mushroom to which the egg yolk liquid has been applied, as well as a slug, and a powdering step of pulverizing the freeze-dried mixture. do.
난황은 루테인, 제아잔틴, 레시틴, 지용성 비타민 A, D, E을 포함하며, 본 발명에서는 난황막을 포함하는 것을 사용할 수 있다. 상기 난황막은 뮤신과 케라틴을 포함하며, 뮤신은 기포안정화 효과를 가지며, 케라틴은 영지버섯 조직을 보호하는 역할을 한다. 또한, 난황에는 레시틴을 다량 포함하는데, 난황 레시틴은 콜레스테롤을 낮추고 두뇌영양공급, 항산화 작용, 혈행을 원활히 하는데 도움을 주는 것으로 알려져 있으며, 더불어 레시틴은 천연유화제로서 영지버섯이 갖는 수용성과 지용성의 유효성분 추출성을 증가시킬 수 있다.Egg yolk includes lutein, zeaxanthin, lecithin, and fat-soluble vitamins A, D, and E, and in the present invention, one containing yolk membrane may be used. The yolk membrane includes mucin and keratin, mucin has a bubble stabilizing effect, and keratin serves to protect the reishi mushroom tissue. In addition, egg yolk contains a large amount of lecithin. Egg yolk lecithin is known to help lower cholesterol, provide brain nutrition, antioxidant action, and facilitate blood circulation. In addition, lecithin is a natural emulsifier, which is a water-soluble and fat-soluble active ingredient of Reishi mushroom. extractability can be increased.
마찬가지로 영지버섯은 상술된 영지버섯 전처리단계에 의해서 전처리된 것을 사용할 수 있으며, 영지버섯 전처리를 통해 난황액의 도포특성 및 영지버섯의 유효성분 추출특성을 더욱 향상시킬 수 있다. 또한, 영지버섯 전처리시 스팀처리는 통해 난황액 도포단계에서 난황액의 침투 및 흡수특성을 더욱 향상시킬 수 있다.Similarly, reishi mushrooms can be used that have been pre-treated by the reishi mushroom pre-treatment step described above, and through the reishi mushroom pre-treatment, the application characteristics of the egg yolk liquid and the extracting characteristics of the active ingredients of the reishi mushroom can be further improved. In addition, it is possible to further improve the penetration and absorption characteristics of the yolk fluid in the step of applying the yolk fluid through steam treatment during pre-treatment of reishi mushroom.
난황액 도포단계에서는 미처리 또는 전처리된 영지버섯에 난황액을 도포하게 되며, 난황액은 인지질의 풍부하여 영지버섯의 지용성 성분의 추출을 도우며, 항산화특성을 가져 영지버섯의 가공시 발생되는 유효성분의 변성 및 소실을 방지할 수 있는 효과가 있다.In the egg yolk solution application step, the egg yolk solution is applied to the untreated or pre-treated reishi mushroom, and the egg yolk solution is rich in phospholipids, which helps to extract the fat-soluble components of the reishi mushroom. It has the effect of preventing degeneration and loss.
난황액은 난황의 균일한 도포를 위해 용매와 난황을 혼합한 것으로, 증류수, 유기용매, 천연표면개질제 또는 이들의 조합 중 어느 하나의 용매 100중량부에 대하여 난황 30 내지 70 중량부를 혼합하여 제조된다.Egg yolk solution is a mixture of a solvent and egg yolk for uniform application of egg yolk, and is prepared by mixing 30 to 70 parts by weight of egg yolk with respect to 100 parts by weight of a solvent of any one of distilled water, organic solvent, natural surface modifier, or a combination thereof. .
바람직하게는, 용매로서 증류수와 천연표면개질제를 5: 1~3의 중량비로 혼합한 것을 사용할 수 있으며, 천연 식물에서 유래된 천연표면개질제를 첨가함으로써 난황액의 영지버섯에 대한 도포특성을 향상시킴은 물론이고, 천연 식물이 갖는 면역력 증진, 피로해소, 항암효과 등의 효과를 부여할 수 있다.Preferably, as a solvent, a mixture of distilled water and a natural surface modifier in a weight ratio of 5: 1 to 3 can be used. Of course, it is possible to impart effects such as immunity enhancement, fatigue relief, and anticancer effect of natural plants.
상기 천연표면개질제는 바코파 몬니에리, 인삼, 도라지, 더덕, 황칠, 대두, 모과 또는 이들의 조합 중 어느 하나의 천연식물로부터 추출되는 것으로, 열수추출, 에탄올 추출 또는 이들의 조합 중 어느 하나의 방법을 이용하여 추출될 수 있다. The natural surface modifier is extracted from any one of natural plants of Bacopa monnieri, ginseng, bellflower, deodeok, hwangchil, soybean, quince, or a combination thereof, hot water extraction, ethanol extraction, or any one method of a combination thereof can be extracted using
열수추출시에는 80 내지 120 ℃, 바람직하게는, 80 내지 110 ℃에서 추출될 수 있으며, 에탄올 추출시에는 40 내지 70 vol% 농도의 에탄올에서 추출공정을 수행할 수 있다.During hot water extraction, extraction may be performed at 80 to 120° C., preferably, at 80 to 110° C., and during ethanol extraction, the extraction process may be performed in ethanol having a concentration of 40 to 70 vol%.
영지버섯에 난황액을 도포하는 방법으로는 분사법, 침지법, 브러쉬를 이용한 도포 또는 이들의 조합 중 어느 하나의 방법을 이용할 수 있으며, 바람직하게는, 침지법을 이용할 수 있다. 침지 및 도포시 온도는 난황액이 응고되지 않도록 35 내지 55 ℃ 하로 제어될 수 있다.As a method of applying the egg yolk solution to the reishi mushroom, any one of a spraying method, an immersion method, an application using a brush, or a combination thereof may be used, and preferably, an immersion method may be used. The temperature during immersion and application may be controlled under 35 to 55° C. so that the egg yolk liquid does not coagulate.
동결건조단계에서는 난황액이 도포된 영지버섯과 헛개, 굼벵이를 동결건조하는 단계로, 동결건조시 동결온도는 -60 내지 -40℃ 에서 수행될 수 있으며, 진공도는 동결된 얼음입자가 승화되는 진공범위이면 특별히 제약받지 않으나 통상 0.5 내지 5 torr로 제어될 수 있다.The freeze-drying step is a step of freeze-drying the reishi mushroom, horseradish, and slugs coated with egg yolk liquid. During freeze-drying, the freezing temperature can be carried out at -60 to -40°C, and the degree of vacuum is a vacuum in which the frozen ice particles are sublimed. If the range is not particularly limited, it can be usually controlled to 0.5 to 5 torr.
분말화단계에서는 동결건조된 혼합물을 분쇄하여 분말화하는 단계로, 제 1실시예에 따른 분말화단계에서는 평균입경 50 내지 500 ㎛를 갖도록 분쇄한다. 이때, 분말화 크기가 50㎛ 미만일 경우에는 응집이 발생될 수 있으며, 500 ㎛를 초과할 경우에는 섭취시 이물감이 발생될 수 있기 때문에 상기 평균입경크기를 벗어나지 않는 것이 바람직하다.In the pulverization step, the freeze-dried mixture is pulverized and pulverized, and in the pulverization step according to the first embodiment, the pulverization is pulverized to have an average particle diameter of 50 to 500 μm. At this time, if the powder size is less than 50㎛, agglomeration may occur, and if it exceeds 500㎛, it is preferable not to deviate from the average particle size because a feeling of foreign body may occur when ingested.
제 2실시예에 분말화단계는 제 1실시예에서 제조된 혼합분말의 표면에 천연표면개질제를 추가로 코팅하는 코팅단계를 더 포함하는 것으로, 상기천연표면개질제에 의해 코팅된 혼합분말은 후공정인 혼합단계(S200)에서 꿀 조성물 내에서 분산 및 혼합특성을 더욱 향상시킬 수 있게 된다.In the second embodiment, the powdering step further includes a coating step of additionally coating a natural surface modifier on the surface of the mixed powder prepared in the first embodiment, and the mixed powder coated by the natural surface modifier is a post-process In the phosphorus mixing step (S200), it is possible to further improve the dispersion and mixing properties in the honey composition.
상기 천연표면개질제는 바코파 몬니에리, 인삼, 도라지, 더덕, 황칠, 대두, 모과 또는 이들의 조합 중 어느 하나의 천연식물로부터 추출되는 것으로, 열수추출, 에탄올 추출 또는 이들의 조합 중 어느 하나의 방법을 이용하여 추출될 수 있다. 열수추출시에는 80 내지 120 ℃, 바람직하게는, 80 내지 110 ℃에서 추출될 수 있으며, 에탄올 추출시에는 40 내지 70 vol% 농도의 에탄올에서 추출공정을 수행할 수 있다.The natural surface modifier is extracted from any one of natural plants of Bacopa monnieri, ginseng, bellflower, deodeok, hwangchil, soybean, quince, or a combination thereof, hot water extraction, ethanol extraction, or any one method of a combination thereof can be extracted using During hot water extraction, extraction may be performed at 80 to 120° C., preferably, at 80 to 110° C., and during ethanol extraction, the extraction process may be performed in ethanol having a concentration of 40 to 70 vol%.
혼합분말의 표면에 천연표면개질제를 코팅하는 방법은 유동층 코팅법, 스프레이 분사법 또는 이들의 조합 중 어느 하나의 방법으로부터 선택될 수 있으며, 바람직하게는, 유동층 코팅법을 이용할 수 있다.The method of coating the natural surface modifier on the surface of the mixed powder may be selected from any one of a fluidized bed coating method, a spray spraying method, or a combination thereof, and preferably, a fluidized bed coating method may be used.
유동층 코팅법은 유동층 코팅장치로 수행되며, 유동층 코팅장치 내부에 혼합분말을 유동시키고, 유동되는 혼합분말에 천연표면개질제를 분사하여 상기 혼합분말의 표면에 천연표면개질제를 코팅할 수 있다.The fluidized bed coating method is performed with a fluidized bed coating device, and the natural surface modifier is coated on the surface of the mixed powder by flowing the mixed powder inside the fluidized bed coating device, and spraying the natural surface modifier to the flowing mixed powder.
이때, 유동층 코팅장치는 흡입 공기량 1 내지 20㎥/sec, 투입관 온도 70 내지 165℃, 분무압력 10 내지 50 bar, 분무속도 1 내지 20kg/hr 로 코팅공정을 수행하되, 천연 표면개질 성분이 코팅된 혼합분말의 크기가 50 내지 500 ㎛의 평균입도를 갖도록 제어될 수 있다.At this time, the fluidized bed coating device performs the coating process at an intake air amount of 1 to 20 m3/sec, an input pipe temperature of 70 to 165° C., a spraying pressure of 10 to 50 bar, and a spraying rate of 1 to 20 kg/hr, but the natural surface modification component is coated The size of the mixed powder can be controlled to have an average particle size of 50 to 500 μm.
이때, 분사되는 천연표면개질제의 농도 및 점도를 제어하여 코팅특성을 제어하는 것도 가능하며, 코팅 초기(전체 코팅시간 중 30% 이하 구간)에는 점도 10 내지 30 cps 를 갖는 1차 천연표면개질제를 분사하고, 코팅 중기 및 말기(전체 코팅시간 중 30% 초과 구간)에는 점도 40 내지 60 cps 를 갖는 2차 1차 천연표면개질제를 분사할 수 있으며, 점도는 증류수, 알코올류 또는 이들의 조합을 이용한 용매를 이용하여 제어될 수 있다. At this time, it is also possible to control the coating properties by controlling the concentration and viscosity of the sprayed natural surface modifier, and in the initial stage of coating (30% or less of the total coating time), the primary natural surface modifier having a viscosity of 10 to 30 cps is sprayed. And, in the middle and late stages of coating (over 30% of the total coating time), the secondary primary natural surface modifier having a viscosity of 40 to 60 cps can be sprayed, and the viscosity is distilled water, alcohol, or a solvent using a combination thereof. can be controlled using
코팅초기에 상대적으로 저점도의 1차 천연표면개질제를 분사함으로써 혼합분말의 표면기공에 1차 천연표면개질제의 흡수 및 침투 특성을 더욱 향상시킬 수 있게 된다.By spraying the relatively low-viscosity primary natural surface modifier at the initial stage of coating, it is possible to further improve the absorption and penetration characteristics of the primary natural surface modifier into the surface pores of the mixed powder.
상기 분말화단계는 제 1실시예에 따른 혼합분말 제조단계(S100)에서도 동일하게 적용할 수 있다.The powdering step may be equally applied to the mixed powder manufacturing step (S100) according to the first embodiment.
상기 혼합단계(S200)에서는 꿀과 혼합분말을 혼합하며, 이때, 꿀은 다른 당류 및 천연감미료로 대체될 수 있으며, 당류 및 천연감미료는 당밀, 대용꿀, 로얄젤리, 프로폴리스, 과당, 프락토올리고당,이소말토올리고당, 조청, 물엿, 설탕, 포도당, 솔비톨, 말리톨, 아라비톨, 고과당옥수수시럽 또는 이들의 조합 중 어느 하나를 포함할 수 있다. 또한, 상기 당류 및 천연감미료는 액상 또는 분말상일 수 있다. In the mixing step (S200), honey and mixed powder are mixed, and at this time, honey can be replaced with other sugars and natural sweeteners, and sugars and natural sweeteners are molasses, substitute honey, royal jelly, propolis, fructose, fructose. Oligosaccharide, isomaltooligosaccharide, corn syrup, starch syrup, sugar, glucose, sorbitol, malitol, arabitol, high fructose corn syrup, or any one of a combination thereof may be included. In addition, the sugar and natural sweetener may be in liquid or powder form.
상기 혼합단계(S200)에서는 꿀 100 중량부에 대하여 혼합분말 0.1 내지 30 중량부를 혼합하며, 이때 상기 혼합분말이 0.1 중량부 미만으로 첨가되면 혼합분말이 갖는 효과가 미미하고, 30중량부를 초과할 경우에는 응집이 발생되거나 섭취시 이물감이 발생되어 기호도를 저하시키기 때문에 상기 중량 범위를 벗어나지 않는 것이 바람직하다. 혼합시 교반속도는 50 내지 150 rpm로 제어될 수 있으며, 15 내지 30분간 교반처리할 수 있다. In the mixing step (S200), 0.1 to 30 parts by weight of the mixed powder is mixed with respect to 100 parts by weight of honey. At this time, when the mixed powder is added in an amount of less than 0.1 parts by weight, the effect of the mixed powder is insignificant, and when it exceeds 30 parts by weight It is preferable not to deviate from the above weight range because aggregation occurs or a feeling of foreign body is generated upon ingestion, thereby reducing the preference. When mixing, the stirring speed may be controlled at 50 to 150 rpm, and stirring may be performed for 15 to 30 minutes.
이하, 본 발명에 따른 영지버섯을 포함하는 꿀 조성물을 설명하도록 한다.Hereinafter, a honey composition comprising reishi mushroom according to the present invention will be described.
본 발명에 따른 영지버섯을 포함하는 꿀 조성물은 꿀에 영지버섯, 헛개, 굼벵이를 포함하는 혼합분말을 혼합한 것을 특징으로 한다.The honey composition comprising reishi mushroom according to the present invention is characterized in that honey is mixed with a mixed powder containing reishi mushroom, horseradish, and slugs.
혼합분말은 영지버섯, 헛개, 굼벵이를 포함하는 것으로, 제 1실시예에 따른 혼합분말은 영지버섯 100중량부에 대하여 헛개 1 내지 5 중량부, 굼벵이 0.1 내지 3 중량부를 혼합한 것으로, 이때, 혼합분말은 영지버섯분말, 헛개분말, 굼벵이 분말을 혼합하거나, 원물 또는 건조된 상태의 원료를 모두 배합한 후 분말화한 것 일 수 있다. 또한, 혼합분말은 영지버섯 100중량부에 대하여 새싹보리 0.1 내지 3중량부, 솔잎 0.5 내지 5 중량부를 추가로 더 포함하는 것도 가능하다.The mixed powder includes reishi mushroom, sagebrush, and slug, and the mixed powder according to the first embodiment is a mixture of 1 to 5 parts by weight of reishi mushroom and 0.1 to 3 parts by weight of slug with respect to 100 parts by weight of reishi mushroom, at this time, The powder may be powdered after mixing reishi mushroom powder, horseradish powder, slug powder, or mixing all raw materials or raw materials in a dried state. In addition, the mixed powder may further include 0.1 to 3 parts by weight of barley sprouts and 0.5 to 5 parts by weight of pine needles based on 100 parts by weight of reishi mushroom.
분말화방법은 열풍건조, 동결건조 또는 이들의 조합 중 어느 하나의 건조방법을 이용할 수 있으며, 바람직하게는, 유효성분의 변성을 최소화할 수 있는 동결건조법을 이용할 수 있다.For the powdering method, any one of hot air drying, freeze drying, or a combination thereof may be used, and preferably, a freeze drying method capable of minimizing denaturation of the active ingredient may be used.
동결건조시 동결온도는 -60 내지 -40℃ 에서 수행될 수 있으며, 진공도는 동결된 얼음입자가 승화되는 진공범위이면 특별히 제약받지 않으나 통상 0.5 내지 5 torr로 제어될 수 있다. 동결건조 후에 평균입경 50 내지 500 ㎛를 갖도록 분쇄처리할 수 있다.During freeze-drying, the freezing temperature can be carried out at -60 to -40°C, and the degree of vacuum is not particularly limited as long as the vacuum range is in which the frozen ice particles are sublimed, but can be controlled to usually 0.5 to 5 torr. After freeze-drying, it may be pulverized to have an average particle diameter of 50 to 500 μm.
영지버섯은 자실체, 균사체 또는 이들의 조합 중 어느 하나를 사용할 수 있으며, 유효성분 추출특성을 향상시키기 위한 영지버섯 전처리단계를 통해 전처리될 수 있다. Reishi mushroom may use any one of fruiting body, mycelium, or a combination thereof, and may be pre-treated through a reishi mushroom pre-treatment step to improve the extraction characteristics of active ingredients.
영지버섯의 전처리는 고압풍 또는 고압수를 이용하여 표면의 이물질 및 포자를 제거하는 1차 공정과 이물질이 제거된 영지버섯의 표면에 체크 무늬의 칼집을 내거나 평균직경 0.1 내지 3mm의 미세 바늘로 단위면적(㎠)당 타공수 3 내지 100이 되도록 펀칭처리하는 2차 공정을 포함할 수 있다.The pre-treatment of reishi mushroom is the primary process of removing foreign substances and spores from the surface using high-pressure wind or high-pressure water, and a checkered cut is made on the surface of the reishi mushroom from which foreign substances have been removed, or a fine needle with an average diameter of 0.1 to 3 mm is used. It may include a secondary process of punching so that the number of perforations per area (cm 2 ) is 3 to 100.
2차 공정에서는 영지버섯을 평균입경 5 내지 15 mm 로 조쇄하는 것도 가능하나, 조쇄공정을 통해 영지버섯 유효성분의 산화가 발생될 수 있기 때문에 영지버섯의 가공 표면적을 지나치게 증가시키지 않도록 칼집을 내거나 펀칭하는 것이 바람직하다.In the second process, it is possible to crush the reishi mushroom to an average particle diameter of 5 to 15 mm. However, since oxidation of the active ingredient of the reishi mushroom may occur through the crushing process, cut or punch the reishi mushroom to avoid excessively increasing the processed surface area of the reishi mushroom. It is preferable to do
또한, 상기 영지버섯 전처리공정은 1차 공정 또는 2차 공정 이후, 스팀처리 및 자외선 조사를 수행할 수 있다.In addition, the reishi mushroom pretreatment process may be performed after the first process or the second process, steam treatment and ultraviolet irradiation.
스팀처리는 물이 끓기시작하면 스팀기에 영지버섯을 투입하여 3 내지 5분간 수행될 수 있으며, 이때, 물 대신에 5 내지 15vol % 의 에탄올 수용액을 이용하는 것도 가능하다. Steam treatment can be performed for 3 to 5 minutes by putting the reishi mushroom in the steamer when the water starts to boil. At this time, it is also possible to use an aqueous solution of 5 to 15 vol % of ethanol instead of water.
자외선 조사는 영지버섯 내의 비타민 D2의 전구체인 에르고스테롤(ergosterol)을 비타민 D2 인 에르고칼시페롤(ergocalciferol)로 전환시키고, 잔여하는 미생물 및 오염물질을 제거하기 위한 단계로, 자외선 조사 영역대는 280-320nm의 파장영역대(UV-B)를 이용할 수 있으며, 자외선 조사시간은 5 내지 30분간 수행될 수 있다.UV irradiation is a step for converting ergosterol, a precursor of vitamin D 2 in Reishi mushroom, to ergocalciferol, which is vitamin D 2 , and removing residual microorganisms and contaminants. A wavelength band (UV-B) of 280-320 nm may be used, and UV irradiation time may be performed for 5 to 30 minutes.
이때, 자외선 조사처리를 처리하기에 앞서 스팀처리를 수행하는 것이 바람직한데, 스팀처리를 통해 영지버섯 조직의 내물질 순환 및 반응성을 증가시킴으로써 자외선 조사에 따른 전환반응이 증대될 수 있다.At this time, it is preferable to perform a steam treatment prior to the UV irradiation treatment. By increasing the internal material circulation and reactivity of the reishi mushroom tissue through the steam treatment, the conversion reaction according to the UV irradiation can be increased.
보다 바람직하게는, 영지버섯 전처리는 1차 공정-2차 공정-스팀처리- 자외선조사를 순차적으로 수행할 수 있다.More preferably, the pre-treatment of reishi mushroom may be sequentially performed by the first process - the second process - steam treatment - ultraviolet irradiation.
제 2실시예에 따른 혼합분말은 영지버섯의 건조, 분말화 등의 가공공정에서 발생되는 유효성분의 변성 및 소실을 방지하기 위하여 영지버섯을 난황액에 처리한 것으로, 제 2실시예에 따른 혼합분말은 영지버섯에 난황액을 도포하고 난황액이 도포된 영지버섯과 헛개, 굼벵이를 동결건조 후 분쇄한 것이다.The mixed powder according to the second embodiment is obtained by treating the reishi mushroom in egg yolk solution in order to prevent denaturation and loss of the active ingredient generated in the processing process such as drying and powdering of the reishi mushroom, and the mixture according to the second embodiment The powder is obtained by applying egg yolk solution to reishi mushrooms and freeze-drying the reishi mushrooms, worms, and slugs coated with egg yolk solution and then pulverizing them.
난황은 루테인, 제아잔틴, 레시틴, 지용성 비타민 A, D, E을 포함하며, 본 발명에서는 난황막을 포함하는 것을 사용할 수 있다. 상기 난황막은 뮤신과 케라틴을 포함하며, 뮤신은 기포안정화 효과를 가지며, 케라틴은 영지버섯 조직을 보호하는 역할을 한다. 또한, 난황에는 레시틴을 다량 포함하는데, 난황 레시틴은 콜레스테롤을 낮추고 두뇌영양공급, 항산화 작용, 혈행을 원활히 하는데 도움을 주는 것으로 알려져 있으며, 더불어 레시틴은 천연유화제로서 영지버섯이 갖는 수용성과 지용성의 유효성분 추출성을 증가시킬 수 있다.Egg yolk includes lutein, zeaxanthin, lecithin, and fat-soluble vitamins A, D, and E, and in the present invention, those containing the yolk membrane may be used. The yolk membrane includes mucin and keratin, mucin has a bubble stabilizing effect, and keratin serves to protect the reishi mushroom tissue. In addition, egg yolk contains a large amount of lecithin. Egg yolk lecithin is known to help lower cholesterol, provide brain nutrition, antioxidant action, and facilitate blood circulation. In addition, lecithin is a natural emulsifier, which is a water-soluble and fat-soluble active ingredient of Reishi mushroom. extractability can be increased.
마찬가지로 영지버섯은 상술된 영지버섯 전처리단계에 의해서 전처리된 것을 사용할 수 있으며, 영지버섯 전처리를 통해 난황액의 도포특성 및 영지버섯의 유효성분 추출특성을 더욱 향상시킬 수 있다. 또한, 영지버섯 전처리시 스팀처리는 통해 난황액 도포단계에서 난황액의 침투 및 흡수특성을 더욱 향상시킬 수 있다.Similarly, reishi mushrooms can be used that have been pre-treated by the reishi mushroom pre-treatment step described above, and through the reishi mushroom pre-treatment, the application characteristics of the egg yolk liquid and the extracting characteristics of the active ingredients of the reishi mushroom can be further improved. In addition, it is possible to further improve the penetration and absorption characteristics of the yolk fluid in the step of applying the yolk fluid through steam treatment during pre-treatment of reishi mushroom.
이후, 미처리 또는 전처리된 영지버섯에 난황액을 도포하게 되며, 난황액은 인지질의 풍부하여 영지버섯의 지용성 성분의 추출을 도우며, 항산화특성을 가져 영지버섯의 가공시 발생되는 유효성분의 변성 및 소실을 방지할 수 있는 효과가 있다.Thereafter, egg yolk liquid is applied to the untreated or pre-treated reishi mushroom, and the egg yolk liquid is rich in phospholipids, which helps to extract the fat-soluble components of reishi mushroom. has the effect of preventing
난황액은 난황의 균일한 도포를 위해 용매와 난황을 혼합한 것으로, 증류수, 유기용매, 천연표면개질제 또는 이들의 조합 중 어느 하나의 용매 100중량부에 대하여 난황 30 내지 70 중량부를 혼합하여 제조된다.Egg yolk solution is a mixture of a solvent and egg yolk for uniform application of egg yolk, and is prepared by mixing 30 to 70 parts by weight of egg yolk with respect to 100 parts by weight of a solvent of any one of distilled water, organic solvent, natural surface modifier, or a combination thereof. .
바람직하게는, 용매로서 증류수와 천연표면개질제를 5: 1~3의 중량비로 혼합한 것을 사용할 수 있으며, 천연 식물에서 유래된 천연표면개질제를 첨가함으로써 난황액의 영지버섯에 대한 도포특성을 향상시킴은 물론이고, 천연 식물이 갖는 면역력 증진, 피로해소, 항암효과 등의 효과를 부여할 수 있다. Preferably, as a solvent, a mixture of distilled water and a natural surface modifier in a weight ratio of 5: 1 to 3 can be used. Of course, it is possible to impart effects such as immunity enhancement, fatigue relief, and anticancer effect of natural plants.
상기 천연표면개질제는 바코파 몬니에리, 인삼, 도라지, 더덕, 황칠, 대두, 모과 또는 이들의 조합 중 어느 하나의 천연식물로부터 추출되는 것으로, 열수추출, 에탄올 추출 또는 이들의 조합 중 어느 하나의 방법을 이용하여 추출될 수 있다. The natural surface modifier is extracted from any one of natural plants of Bacopa monnieri, ginseng, bellflower, deodeok, hwangchil, soybean, quince, or a combination thereof, hot water extraction, ethanol extraction, or any one method of a combination thereof can be extracted using
열수추출시에는 80 내지 120 ℃, 바람직하게는, 80 내지 110 ℃에서 추출될 수 있으며, 에탄올 추출시에는 40 내지 70 vol% 농도의 에탄올에서 추출공정을 수행할 수 있다.During hot water extraction, extraction may be performed at 80 to 120° C., preferably, at 80 to 110° C., and during ethanol extraction, the extraction process may be performed in ethanol having a concentration of 40 to 70 vol%.
영지버섯에 난황액을 도포하는 방법으로는 분사법, 침지법, 브러쉬를 이용한 도포 또는 이들의 조합 중 어느 하나의 방법을 이용할 수 있으며, 바람직하게는, 침지법을 이용할 수 있다. 침지 및 도포시 온도는 난황액이 응고되지 않도록 35 내지 55 ℃ 하로 제어될 수 있다.As a method of applying the egg yolk solution to the reishi mushroom, any one of a spraying method, an immersion method, an application using a brush, or a combination thereof may be used, and preferably, an immersion method may be used. The temperature during immersion and application may be controlled under 35 to 55° C. so that the egg yolk liquid does not coagulate.
난황액이 도포된 영지버섯과 헛개, 굼벵이는 동결건조되며, 동결건조시 동결온도는 -60 내지 -40℃ 에서 수행될 수 있으며, 진공도는 동결된 얼음입자가 승화되는 진공범위이면 특별히 제약받지 않으나 통상 0.5 내지 5 torr로 제어될 수 있다.Reishi mushrooms, horseradish, and slugs coated with egg yolk liquid are freeze-dried, and the freezing temperature during freeze-drying can be carried out at -60 to -40 ° C. Usually 0.5 to 5 torr can be controlled.
동결건조된 혼합물은 평균입경 50 내지 500 ㎛를 갖도록 분말화되며(제 1실시예에 따른 분말), 이때, 분말화 크기가 50㎛ 미만일 경우에는 응집이 발생될 수 있으며, 500 ㎛를 초과할 경우에는 섭취시 이물감이 발생될 수 있기 때문에 상기 평균입경크기를 벗어나지 않는 것이 바람직하다.The freeze-dried mixture is powdered to have an average particle diameter of 50 to 500 μm (powder according to the first embodiment), at this time, when the powder size is less than 50 μm, aggregation may occur, and when it exceeds 500 μm It is preferable not to deviate from the above average particle size because a feeling of foreign body may occur when ingested.
제 2실시예에 따른 분말은 제 1실시예에 따른 분말의 표면에 천연표면개질제를 추가로 코팅한 것으로, 상기 천연표면개질제에 의해 코팅된 혼합분말은 후공정인 꿀 조성물 내에서 분산 및 혼합특성을 더욱 향상시킬 수 있게 된다.The powder according to the second embodiment is an additional coating of a natural surface modifier on the surface of the powder according to the first embodiment. can be further improved.
상기 천연표면개질제는 바코파 몬니에리, 인삼, 도라지, 더덕, 황칠, 대두, 모과 또는 이들의 조합 중 어느 하나의 천연식물로부터 추출되는 것으로, 열수추출, 에탄올 추출 또는 이들의 조합 중 어느 하나의 방법을 이용하여 추출될 수 있다. 열수추출시에는 80 내지 120 ℃, 바람직하게는, 80 내지 110 ℃에서 추출될 수 있으며, 에탄올 추출시에는 40 내지 70 vol% 농도의 에탄올에서 추출공정을 수행할 수 있다.The natural surface modifier is extracted from any one of natural plants of Bacopa monnieri, ginseng, bellflower, deodeok, hwangchil, soybean, quince, or a combination thereof, hot water extraction, ethanol extraction, or any one method of a combination thereof can be extracted using During hot water extraction, extraction may be performed at 80 to 120° C., preferably, at 80 to 110° C., and during ethanol extraction, the extraction process may be performed in ethanol having a concentration of 40 to 70 vol%.
혼합분말의 표면에 천연표면개질제를 코팅하는 방법은 유동층 코팅법, 스프레이 분사법 또는 이들의 조합 중 어느 하나의 방법으로부터 선택될 수 있으며, 바람직하게는, 유동층 코팅법을 이용할 수 있다.The method of coating the natural surface modifier on the surface of the mixed powder may be selected from any one of a fluidized bed coating method, a spray spraying method, or a combination thereof, and preferably, a fluidized bed coating method may be used.
유동층 코팅법은 유동층 코팅장치로 수행되며, 유동층 코팅장치 내부에 혼합분말을 유동시키고, 유동되는 혼합분말에 천연표면개질제를 분사하여 상기 혼합분말의 표면에 천연표면개질제를 코팅할 수 있다.The fluidized bed coating method is performed with a fluidized bed coating device, and the natural surface modifier is coated on the surface of the mixed powder by flowing the mixed powder inside the fluidized bed coating device, and spraying the natural surface modifier to the flowing mixed powder.
이때, 유동층 코팅장치는 흡입 공기량 1 내지 20㎥/sec, 투입관 온도 70 내지 165℃, 분무압력 10 내지 50 bar, 분무속도 1 내지 20kg/hr 로 코팅공정을 수행하되, 천연표면개질 성분이 코팅된 혼합분말의 크기가 50 내지 500 ㎛의 평균입도를 갖도록 제어될 수 있다.At this time, the fluidized bed coating apparatus performs the coating process at an intake air volume of 1 to 20 m3/sec, an input pipe temperature of 70 to 165° C., a spraying pressure of 10 to 50 bar, and a spraying rate of 1 to 20 kg/hr, but the natural surface modification component is coated The size of the mixed powder can be controlled to have an average particle size of 50 to 500 μm.
이때, 분사되는 천연표면개질제의 농도 및 점도를 제어하여 코팅특성을 제어하는 것도 가능하며, 코팅 초기(전체 코팅시간 중 30% 이하 구간)에는 점도 10 내지 30 cps 를 갖는 1차 천연표면개질제를 분사하고, 코팅 중기 및 말기(전체 코팅시간 중 30% 초과 구간)에는 점도 40 내지 60 cps 를 갖는 2차 1차 천연표면개질제를 분사할 수 있으며, 점도는 증류수, 알코올류 또는 이들의 조합을 이용한 용매를 이용하여 제어될 수 있다. At this time, it is also possible to control the coating properties by controlling the concentration and viscosity of the sprayed natural surface modifier, and in the initial stage of coating (30% or less of the total coating time), the primary natural surface modifier having a viscosity of 10 to 30 cps is sprayed. And, in the middle and late stages of coating (over 30% of the total coating time), the secondary primary natural surface modifier having a viscosity of 40 to 60 cps can be sprayed, and the viscosity is distilled water, alcohol, or a solvent using a combination thereof. can be controlled using
코팅초기에 상대적으로 저점도의 1차 천연표면개질제를 분사함으로써 혼합분말의 표면기공에 1차 천연표면개질제의 흡수 및 침투 특성을 더욱 향상시킬 수 있게 된다.By spraying the relatively low-viscosity primary natural surface modifier at the initial stage of coating, it is possible to further improve the absorption and penetration characteristics of the primary natural surface modifier into the surface pores of the mixed powder.
상기 분말화공정은 제 1실시예에 따른 혼합분말에서도 동일하게 적용할 수 있다.The powdering process can be applied equally to the mixed powder according to the first embodiment.
제조된 혼합분말은 꿀과 혼합되며, 이때, 꿀은 다른 당류 및 천연감미료로 대체될 수 있으며, 당류 및 천연감미료는 당밀, 대용꿀, 로얄젤리, 프로폴리스, 과당, 프락토올리고당,이소말토올리고당, 조청, 물엿, 설탕, 포도당, 솔비톨, 말리톨, 아라비톨, 고과당옥수수시럽 또는 이들의 조합 중 어느 하나를 포함할 수 있다. 또한, 상기 당류 및 천연감미료는 액상 또는 분말상일 수 있다. The prepared mixed powder is mixed with honey, and at this time, honey can be replaced with other sugars and natural sweeteners, and sugars and natural sweeteners are molasses, honey substitute, royal jelly, propolis, fructose, fructooligosaccharide, isomaltooligosaccharide , grain syrup, starch syrup, sugar, glucose, sorbitol, malitol, arabitol, high fructose corn syrup, or any one of a combination thereof. In addition, the sugar and natural sweetener may be in liquid or powder form.
이때, 꿀 100 중량부에 대하여 혼합분말 0.1 내지 30 중량부를 혼합하며, 이때 상기 혼합분말이 0.1 중량부 미만으로 첨가되면 혼합분말이 갖는 효과가 미미하고, 30중량부를 초과할 경우에는 응집이 발생되거나 섭취시 이물감이 발생되어 기호도를 저하시키기 때문에 상기 중량 범위를 벗어나지 않는 것이 바람직하다. 혼합시 교반속도는 50 내지 150 rpm로 제어될 수 있으며, 15 내지 30분간 교반처리할 수 있다. At this time, 0.1 to 30 parts by weight of the mixed powder is mixed with respect to 100 parts by weight of honey. At this time, when the mixed powder is added in an amount of less than 0.1 parts by weight, the effect of the mixed powder is insignificant, and when it exceeds 30 parts by weight, agglomeration occurs or It is preferable not to deviate from the above weight range because a feeling of foreign body is generated upon ingestion, thereby reducing the preference. When mixing, the stirring speed may be controlled at 50 to 150 rpm, and stirring may be performed for 15 to 30 minutes.
본 발명에 따른 영지버섯을 포함하는 꿀 조성물은 영양학적 가치 및 기호도가 높으며, 차, 음료, 음료첨가물, 식품첨가물, 기능성 당류대용 등의 식품조성물 및 기능성식품에 적용되어 사용될 수 있다.The honey composition containing reishi mushroom according to the present invention has high nutritional value and preference, and can be applied to food compositions and functional foods such as tea, beverages, beverage additives, food additives, functional sugar substitutes, and the like.
이하, 본 발명을 바람직한 일 실시예를 참조하여 다음에서 구체적으로 상세하게 설명한다. 단, 다음의 실시예는 본 발명을 구체적으로 예시하기 위한 것이며, 이것만으로 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail below with reference to a preferred embodiment. However, the following examples are intended to specifically illustrate the present invention, and are not limited thereto.
1. 혼합분말1. Mixed powder
1-1. 영지버섯의 준비1-1. Preparation of reishi mushroom
수확한 영지버섯 자실체를 준비하여, 1차로 고압풍으로 표면의 이물질을 제거하고, 2차로 고압수로 잔여 이물질 및 포자를 제거하였으며, 무균박스에 보관하여 실험에 사용하였다.Harvested reishi mushroom fruiting bodies were prepared, firstly to remove foreign substances from the surface with high-pressure air, and secondly to remove residual foreign substances and spores with high-pressure water, and stored in a sterile box for use in the experiment.
영지버섯의 전처리방법에 따른 유효성분의 추출특성을 확인하기 위하여 하기의 표 1 내지 표 4와 같이 실험설계를 하였다. 확인대상 유효성분은 가노데릭산과 에르고칼시페롤이며, 각 실험 후 가노데릭산과 에르고칼시페롤 함량을 측정하였으며, 가노데릭산과 에르고칼시페롤의 측정방법은 하기와 같다.In order to confirm the extraction characteristics of the active ingredients according to the pretreatment method of reishi mushroom, an experimental design was carried out as shown in Tables 1 to 4 below. The active ingredients to be confirmed are ganoderic acid and ergocalciferol, and the content of ganoderic acid and ergocalciferol was measured after each experiment. The measurement method of ganoderic acid and ergocalciferol is as follows.
가노데릭산(ganoderic acids)의 함량은 고성능 액체 크로마토그래피(High-Performance Liquid Chromatography, HPLC)를 이용하여 측정하였으며, 컬럼은 waters sunfire C18 150 mm×4.6 mm of 5 μm particle size 를 이용하였다. 이동상은 Eluent A: 100% Acetonitrile, Eluent B: 0.05% Phosporic acid를 사용하였으며, Flow rate은 1 ml/min (gradient mode)로 하였으며, Injection volume은 10 μl로 하여 분석을 수행하였다. 표준물질은 ganoderic acid standard(Sigma)를 사용하였다. ganoderic acid 를 3차 증류수로 희석하고 표준용액을 조제하여 HPLC 분석을 실시하고 peak area로부터 검량선을 작성하여 시료 내 성분량을 정량하였다.The content of ganoderic acids was measured using High-Performance Liquid Chromatography (HPLC), and the column was waters sunfire C18 150 mm×4.6 mm of 5 μm particle size. As the mobile phase, Eluent A: 100% Acetonitrile, Eluent B: 0.05% Phosporic acid was used, the flow rate was 1 ml/min (gradient mode), and the injection volume was 10 μl. As a standard, ganoderic acid standard (Sigma) was used. The ganoderic acid was diluted with tertiary distilled water, a standard solution was prepared, and HPLC analysis was performed. A calibration curve was drawn from the peak area to quantify the amount of components in the sample.
에르고칼시페롤(ergocalciferol)분석은 Supersil C18 컬럼 ODS-1(particle size 5 μm, 46×250 mm)을 장착한 Dionex 3000 HPLC system(Thermo Fisher, Sunnyvale, CA,USA)을 이용하여 분석하였다. 시료는 10 μL를 주입하였고 이동상 용매는 A용매 acetonitrile과 B용매 메탄올을 이용하여 gradient(0~5분 동안 B용매 80%, 5~20분 동안 B용매 20%, 20~30분 동안 B용매 10%)로 분석하였다. 유속은 18 mL/min으로 실시하고 컬럼 온도는 30℃, 측정파장은 UV 검출기(282 nm)를 이용해 실시하였다.Ergocalciferol analysis was performed using a Dionex 3000 HPLC system (Thermo Fisher, Sunnyvale, CA, USA) equipped with a Supersil C18 column ODS-1 (particle size 5 μm, 46×250 mm). 10 μL of the sample was injected, and the mobile phase solvent was gradient (solvent B 80% for 0-5 minutes, solvent B 20% for 5-20 minutes, solvent B 10 for 20-30 minutes using acetonitrile for solvent A and methanol for solvent B. %). The flow rate was 18 mL/min, the column temperature was 30°C, and the measurement wavelength was performed using a UV detector (282 nm).
하기의 표 1은 영지버섯의 물리적 처리에 따른 가노데릭산 함량을 보여준다.Table 1 below shows the ganoderic acid content according to the physical treatment of reishi mushroom.
펀칭처리는 평균직경 1mm의 미세바늘을 이용하여 단위면적(㎠)당 타공수 3~5로 처리하였으며, 조쇄는 절단기를 사용하여 수행되었으며, 평균직경 10mm 를 갖도록 조쇄처리되었다. 이후 이를 실내온도 22~23℃에서 24시간 공기 중에 방치한 후 가노데릭산 함량을 측정하였다.Punching treatment was performed using a microneedle having an average diameter of 1 mm, and the number of perforations per unit area (cm 2 ) was 3 to 5, and crushing was performed using a cutter, and crushing treatment was performed to have an average diameter of 10 mm. After that, it was left in the air at a room temperature of 22 to 23 ° C for 24 hours, and the content of ganoderic acid was measured.
그 결과, 가노데릭산 함량은 미처리 > 펀칭처리 > 조쇄처리순으로 확인되었는데, 이를 통해 영지버섯의 물리적 처리에 따라 유효성분의 함량이 상이하며, 영지버섯의 조쇄 및 분쇄는 산화를 촉진시켜 유효성분의 추출에 영향을 줄 수 있음을 확인하였다. 추후 실험에는 난황액의 흡수성을 고려하여 펀칭가공된 영지버섯을 사용하였다.As a result, the content of ganoderic acid was confirmed in the order of untreated > punching > crushed treatment. Through this, the content of active ingredients differs depending on the physical treatment of reishi mushroom. It was confirmed that it may affect the extraction of For subsequent experiments, punching-processed reishi mushrooms were used in consideration of the absorbability of egg yolk fluid.
하기의 표 2는 스팀처리 및 자외선처리에 따른 가노데릭산과 에르고칼시페롤 함량을 보여준다. 이때, 스팀처리는 4분간 수행되었고, 자외선조사(UV-B)는 10분간 수행되었다.Table 2 below shows the contents of ganoderic acid and ergocalciferol according to steam treatment and UV treatment. At this time, steam treatment was performed for 4 minutes, and ultraviolet irradiation (UV-B) was performed for 10 minutes.
그 결과, 가노데릭산 함량은 스팀-자외선조사 > 자외선조사-스팀 > 스팀 > 자외선조사 > 미처리 순으로 확인되었고, 에르고칼시페롤 함량은 스팀-자외선조사 > 자외선조사-스팀 > 자외선조사 > 스팀 > 미처리 순으로 확인되었다. 이를 통해 스팀처리 및 자외선처리가 유효성분의 추출에 영향을 줌을 확인할 수 있었으며, 특히 스팀처리와 자외선조사를 모두 처리하였을 때 유효성분의 추출특성이 우수하였다.As a result, the ganoderic acid content was confirmed in the order of steam-ultraviolet irradiation > UV irradiation-steam > steam > UV irradiation > untreated, and the ergocalciferol content was confirmed by steam-ultraviolet irradiation > UV irradiation-steam > UV irradiation > steam > It was confirmed in unprocessed order. Through this, it was confirmed that steam treatment and UV treatment had an effect on the extraction of active ingredients.
이때, 자외선조사를 먼저하는 것 보다 스팀처리를 먼저할 경우 유효성분의 추출특성이 더욱 우수하였는데, 이는 스팀처리를 통해 조직을 활성화하여 자외선조사 효율을 더욱 향상시킬 수 있음에 기인한 것으로 판단하였다. 추후 실험에는 스팀-자외선조사처리된 영지버섯을 사용하였다.At this time, when steam treatment was performed before UV irradiation first, the extraction characteristics of active ingredients were better, which was determined to be due to the fact that UV irradiation efficiency could be further improved by activating tissue through steam treatment. For subsequent experiments, steam-ultraviolet irradiated reishi mushrooms were used.
하기의 표 3은 난황액 처리유무 및 건조온도에 따른 가노데릭산과 에르고칼시페롤 함량을 보여준다. 이때, 난황액은 난황막이 존재하는 신선한 난황과 증류수를 1: 2의 중량비로 혼합하여 준비하였으며, 전처리된 영지버섯을 난황액에 10분간 침지하여 영지버섯에 난황액을 도포 및 흡수시켰다. 이후, 건조공정을 수행하였으며, 건조시 2가지 조건 하(고온건조 80℃, 동결건조 -40℃)에서 수행하였다.Table 3 below shows the contents of ganoderic acid and ergocalciferol according to the presence or absence of egg yolk solution treatment and drying temperature. At this time, the yolk liquid was prepared by mixing fresh egg yolk with yolk film and distilled water in a weight ratio of 1: 2, and the pre-treated reishi mushroom was immersed in the yolk liquid for 10 minutes to apply and absorb the yolk liquid on the reishi mushroom. Thereafter, a drying process was performed, and drying was performed under two conditions (high temperature drying 80° C., freeze drying -40° C.).
그 결과, 각각 난황액 처리 > 난황액 미처리, 동결건조 > 80℃ 건조 순으로 가노데릭산과 에르고칼시페롤 함량이 우수함을 확인할 수 있었으며, 특히, 난황액을 도포한 후 동결건조처리한 그룹에서 함량이 가장 높게 측정되었다. 이는 난황액 처리는 유효성분의 추출특성을 향상시키며, 동결건조시 유효성분의 소실을 최소화할 수 있음에 기인한 것으로 판단하였다.As a result, it was confirmed that the contents of ganoderic acid and ergocalciferol were excellent in the order of yolk solution treatment > untreated egg yolk solution, freeze drying > drying at 80 ° C. In particular, the content in the lyophilized group after applying the egg yolk solution This was the highest measured. This was determined to be due to the fact that egg yolk solution treatment improves the extraction characteristics of the active ingredient and can minimize the loss of the active ingredient during freeze-drying.
1-2. 굼벵이와 헛개1-2. slugs and worms
헛개원료는 헛개열매 에탄올추출물을 감압농축 및 동결건조하여 분말화한 것을 준비하였고, 굼벵이는 동결건조한 것을 준비하였다. As a raw material for hutgae, ethanol extract from hutgae fruit was concentrated under reduced pressure and freeze-dried to prepare a powder, and slugs were prepared by freeze-drying.
1-3. 혼합 및 코팅처리1-3. Mixing and coating
난황액이 처리된 영지버섯을 동결건조하여 영지버섯분말을 준비하였고, 영지버섯분말 100g에 헛개분말 3g과 굼벵이분말 2g을 혼합하여 평균입경 85㎛를 갖도록 분쇄하여 혼합분말을 준비하였다.Reishi mushroom powder treated with egg yolk solution was freeze-dried to prepare reishi mushroom powder, and 100 g of reishi mushroom powder was mixed with 3 g of horseradish powder and 2 g of slug powder, and ground to have an average particle diameter of 85 μm to prepare a mixed powder.
천연표면개질제의 코팅유무 및 코팅방법에 따른 응집특성 및 분산성을 확인하기 위하여 하기의 표 4와 같이 실험설계하였으며, 응집 및 분산특성은 제타전위측정장치(Malvern사의 Zeta-Sizer)를 이용하여 확인하였다. Experimental design was designed as shown in Table 4 below to confirm the presence or absence of coating of the natural surface modifier and the cohesive properties and dispersibility according to the coating method. did.
천연표면개질제는 도라지와 바코파 몬니에리의 열수추출물을 준비하였으며, 점도는 32 cps 로 확인되었다. 천연표면개질제의 점도에 따른 코팅특성을 확인하기 위하여 증류수를 희석하여 점도 15 cps를 갖는 천연표면개질제를 추가로 준비하였다.As a natural surface modifier, hot water extracts of bellflower and bacopa monnieri were prepared, and the viscosity was confirmed to be 32 cps. In order to check the coating properties according to the viscosity of the natural surface modifier, distilled water was diluted to prepare a natural surface modifier having a viscosity of 15 cps.
중기/말기 32cpsInitial 15cps
Mid/late 32cps
제타전위는 mV 단위로 측정이 되며 절대치가 커지면 정전기적 반발력이 커지므로 분산성은 좋게 되고, 제타전위가 0 에 가까워지면 불안정하게 되어 물과의 친화력이 낮아 나노입자가 부유하거나 침강하는 등 응집하기가 쉬워진다. 통상적으로 제타전위가 ±30~±60 mV일 때 분산성 및 안정성이 우수한 상태로 볼 수 있으며, ±30 미만일 경우에는 분산안정성이 떨어지고, 응집이 잘 발생되는 상태로 볼 수 있다.The zeta potential is measured in mV, and when the absolute value increases, the electrostatic repulsive force increases, so the dispersibility is good. it gets easier Generally, when the zeta potential is ±30∼±60 mV, it can be seen that the dispersion and stability are excellent, and when the zeta potential is less than ±30, the dispersion stability is deteriorated and aggregation can be seen well.
그 결과, 천연표면개질제를 도포한 그룹이 미처리 그룹보다 제타전위값이 높게 측정되어 분산 안정성이 우수하고 응집의 발생을 최소화할 수 있음을 확인할 수 있었다. 한편, 천연표면개질제를 도포하는 경우 도포방법 및 점도에 따라 제타전위 절대값이 상이하게 측정되었는데, 코팅방법의 경우 유동층코팅법 > 스프레이분사법 순으로 측정되었고, 점도의 경우 초기에 점도를 낮게 설계할 경우 제타전위가 높게 측정되었다. 유동층코팅법이 혼합분말을 보다 균일하게 코팅할 수 있고, 초기 점도를 낮게 제어할 경우 분말 기공에 충진효과 우수하여 제타전위가 우수함을 확인할 수 있었다.As a result, it was confirmed that the group to which the natural surface modifier was applied had a higher zeta potential value than the untreated group, so that the dispersion stability was excellent and the occurrence of aggregation could be minimized. On the other hand, when the natural surface modifier was applied, the absolute value of the zeta potential was measured differently depending on the application method and the viscosity. In this case, the zeta potential was measured to be high. It was confirmed that the fluidized bed coating method can coat the mixed powder more uniformly, and when the initial viscosity is controlled to be low, the filling effect of the powder pores is excellent, and the zeta potential is excellent.
2. 꿀과의 혼합2. Mix with honey
상기 실험 1-3.의 미처리 분말과 유동층코팅된 분말(32cps의 천연표면개질제 코팅)을 벌꿀 300g에 50g 첨가하고, 50rpm에서 30분간 교반하여 교반직후와 교반 60일 후 육안상 변화를 관찰하였다. 50 g of the untreated powder and fluidized bed coated powder (32 cps of natural surface modifier coating) of Experiment 1-3. was added to 300 g of honey, and the mixture was stirred at 50 rpm for 30 minutes to observe changes in visual appearance immediately after stirring and 60 days after stirring.
그 결과, 미처리 분말을 함유한 꿀조성물(이하, 꿀조성물 A)과 유동층코팅처리분말을 함유한 꿀조성물(이하, 꿀조성물 B)모두 교반 직후에는 응집이 확인되지 않았으나, 교반 60일 후에는 꿀 조성물 B에서는 응집이 확인되지 않은 반면, 꿀 조성물 A에서는 약 15~30%의 응집이 확인되었다. 이를 통해 혼합 분말의 처리 방법이 장기보관성 및 제품성에 영향을 끼침을 확인할 수 있었다.As a result, agglomeration was not confirmed immediately after stirring in both the honey composition containing untreated powder (hereinafter, honey composition A) and the honey composition containing fluidized bed coating powder (hereinafter, honey composition B), but after 60 days of stirring, honey Aggregation was not observed in composition B, whereas aggregation of about 15-30% was confirmed in honey composition A. Through this, it was confirmed that the treatment method of the mixed powder had an effect on long-term storage and productability.
3. 항산화 특성 측정3. Measurement of antioxidant properties
제조된 혼합분말의 항산화 효과는 총 페놀함량, 총 플라보노이드 함량, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 소거능을 측정하여 확인하였으며, 항염효과는 Nitric oxide (NO) 생성값을 측정하여 확인하였다. The antioxidant effect of the prepared mixed powder was confirmed by measuring the total phenol content, total flavonoid content, and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging ability, and the anti-inflammatory effect was confirmed by measuring the nitric oxide (NO) production value. did.
3-1. 총 phenol 함량 측정3-1. Determination of total phenol content
phenol 함량을 측정하기 위하여 시료용액 1 ml에 50% Foiln-Ciocalteu’phenol reagent 0.5 ml를 가하여 실온에서 3 min간 반응시켰다. 반응용액에 Na2CO3 포화용액 1 ml와 7.5 ml 증류수를 차례로 혼합하여 30 min간 정치시킨 뒤, 12,000 rpm에서 10 min간 원심분리한 후 상청액을 취해 760 nm에서 흡광도를 측정하였다. 총 phenol 함량은 gallic acid를 표준물질로 이용하여 작성한 검량선에 따라 함량을 구하였으며 측정단위로는 GAE (Gallic acid equivalent)/g을 사용하였다.To measure the phenol content, 0.5 ml of 50% Foiln-Ciocalteu'phenol reagent was added to 1 ml of the sample solution and reacted at room temperature for 3 min. 1 ml of Na 2 CO 3 saturated solution and 7.5 ml of distilled water were sequentially mixed with the reaction solution, left still for 30 min, centrifuged at 12,000 rpm for 10 min, and the supernatant was taken and absorbance was measured at 760 nm. The total phenol content was calculated according to a calibration curve prepared using gallic acid as a standard material, and GAE (Gallic acid equivalent)/g was used as the measurement unit.
3-2. 총 flavonoid 함량 측정3-2. Determination of total flavonoid content
flavonoid 함량을 측정하기 위하여 각 샘플 0.1 ml와 80% 에탄올 0.9 ml을 혼합한 혼합물 0.5 ml에 10% aluminium niatate와 1M potassium acetate 0.1 ml 그리고 80% 에탄올 4.3 ml을 가하여 실온에 40 min 방치한 뒤 415 nm에서 흡광도를 측정하였으며, quercetin을 이용하여 작성한 표준곡선으로부터 함량을 구하였다.To measure the flavonoid content, to 0.5 ml of a mixture of 0.1 ml of each sample and 0.9 ml of 80% ethanol, 0.1 ml of 10% aluminum niatate, 1M potassium acetate, and 4.3 ml of 80% ethanol were added, left at room temperature for 40 min, and then 415 nm Absorbance was measured in , and the content was obtained from a standard curve prepared using quercetin.
3-3. 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 소거능 측정3-3. Measurement of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity
최종 농도가 100 (μg/ml)의 농도로 될 수 있게 희석시켰으며, 에탄올에 용해시킨 0.2 mM의 DPPH 용액 150 μl와 시료를 각각 100 μl씩 혼합하여 37℃에서 30 min 간 반응 시켰다. 반응 후 517 nm에서 흡광도를 측정하였다. 시료액의 대조군은 증류수를 넣었으며, DPPH 용액의 대조군으로써는 에탄올을 넣어 보정값을 얻었다. DPPH 자유라디칼 소거율은 하기의 식에 따라 계산하였다.The final concentration was diluted to a concentration of 100 (μg/ml), and 150 μl of 0.2 mM DPPH solution dissolved in ethanol and 100 μl of each sample were mixed and reacted at 37° C. for 30 min. After the reaction, absorbance was measured at 517 nm. As a control of the sample solution, distilled water was added, and as a control of the DPPH solution, ethanol was added to obtain a correction value. The DPPH free radical scavenging rate was calculated according to the following formula.
DPPH radical scavenging activity (%) = 100-[(As-Ab)x100/Ac] DPPH radical scavenging activity (%) = 100-[(As-Ab)x100/Ac]
As는 농도별 시료를 첨가한 실험군, Ab는 blank를 첨가한 대조군, Ac는 시료를 첨가하지 않은 대조군의 흡광도 값을 뜻한다.As denotes the absorbance value of the experimental group to which samples were added by concentration, Ab denotes the control group to which blank was added, and Ac denotes the absorbance value of the control group to which no sample was added.
4. 항염 특성 측정4. Determination of anti-inflammatory properties
4-1. Nitric oxide (NO) 생성 측정4-1. Nitric oxide (NO) production measurement
NO의 농도는 배양액 내의 NO농도를 griess reagent system을 이용하여 측정하였다. RAW 264.7 세포를 96 well plate에 1.5×105 cells/well로 분주하여 24 h 동안 배양 하였다. 배양 후 새로운 배양액으로 교체하였고 시료를 100(μg/ml)의 농도와 LPS 1μg/ml의 농도를 처리하여 다시 24 h 동안 배양하였다. N1 buffer 50 μl를 각 well에 처리하여 10 min간 상온에서 반응 한 후, N2 buffer 50 μl를 각 well에 처리하고 10 min간 반응시켰다. 반응 후 540 nm에서 흡광도를 측정하였다. Nitrite standard의 농도별 표준곡선을 이용하여 배양액의 NO 농도를 결정하였다.The concentration of NO was measured using the griess reagent system for the concentration of NO in the culture medium. RAW 264.7 cells were seeded in a 96-well plate at 1.5×10 5 cells/well and cultured for 24 h. After incubation, it was replaced with a new culture medium, and the sample was treated with a concentration of 100 (μg/ml) and a concentration of 1 μg/ml of LPS and incubated for 24 h again. 50 μl of N1 buffer was treated in each well and reacted at room temperature for 10 min. Then, 50 μl of N 2 buffer was treated in each well and reacted for 10 min. After the reaction, absorbance was measured at 540 nm. The NO concentration of the culture medium was determined using a standard curve for each concentration of nitrite standard.
5. 항산화 및 항염특성5. Antioxidant and anti-inflammatory properties
비교그룹으로 시판 영지버섯 동결건조분말, 헛개 동결건조분말, 굼벵이 동결건조분말을 준비하였으며, 본 발명에 의해 제조된 혼합분말과 항산화 및 항염효과를 비교하였다(표 6)As a comparison group, commercially available freeze-dried powder of reishi mushroom, freeze-dried powder of horseradish, and freeze-dried powder of slugs were prepared, and the antioxidant and anti-inflammatory effects were compared with the mixed powder prepared by the present invention (Table 6).
(mg/100g)total phenol
(mg/100g)
(mg/100g) Total flavonoid
(mg/100g)
그 결과, 본 발명에 따른 혼합분말의 항산화 및 항염효과가 비교그룹 대비 월등히 우수함을 확인할 수 있으며, 이는 본 발명에 따른 제조방법에 기인한 것으로 판단하였다.As a result, it can be confirmed that the antioxidant and anti-inflammatory effects of the mixed powder according to the present invention are significantly superior to those of the comparative group, which was determined to be due to the manufacturing method according to the present invention.
꿀 조성물과 물을 희석하여 차를 제조하여 관능테스트를 실시하였으며, 냄새, 맛 및 전체 기호도를 확인하였다. 10~40대 남녀 10명을 대상으로 10점 척도법으로 측정하여 그 평균값을 하기 표 7에 나타내었다. (10점: 매우 좋음, 1점: 매우나쁨). By diluting the honey composition and water to prepare tea, a sensory test was performed, and the odor, taste, and overall preference were confirmed. 10 men and women in their 10s and 40s were measured using a 10-point scale method, and the average values thereof are shown in Table 7 below. (10 points: very good, 1 point: very poor).
관능테스트 결과, 10점 척도 기준으로 냄새가 9.2, 맛 8.9, 기호도가 9.1로 우수하게 측정되어 건강학적 측면은 물론이고, 기호도가 높아 상품성 또한 우수할 것으로 예상하였다. As a result of the sensory test, on a 10-point scale, the smell was measured to be 9.2, the taste was 8.9, and the preference was 9.1.
이상과 같이 본 발명은 첨부된 도면을 참조하여 바람직한 실시예를 중심으로 설명하였지만 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 본 발명의 특허청구범위에 기재된 기술적 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 또는 변형하여 실시할 수 있다. 따라서 본 발명의 범주는 이러한 많은 변형의 예들을 포함하도록 기술된 청구범위에 의해서 해석되어야 한다.As described above, the present invention has been mainly described with reference to the accompanying drawings, but those of ordinary skill in the art to which the present invention pertains within the scope not departing from the technical spirit and scope described in the claims of the present invention. Various modifications or variations of the present invention can be practiced. Accordingly, the scope of the present invention should be construed by the appended claims including examples of many such modifications.
Claims (6)
상기 혼합분말은 영지버섯, 헛개, 굼벵이를 포함하며,
상기 혼합분말은
영지버섯에 난황액을 도포하고, 난황액이 도포된 영지버섯과 헛개, 굼벵이를 동결건조한 후 분쇄하여 분말화하고, 분쇄된 분말에 천연표면개질제를 코팅한 것이며,
상기 천연표면개질제는 바코파 몬니에리, 인삼, 도라지, 더덕, 황칠, 대두, 모과 또는 이들의 조합 중 어느 하나의 천연식물로부터 추출되는 것임을 특징으로 하는
영지버섯을 포함하는 꿀 조성물.
Contains 0.1 to 30 parts by weight of mixed powder based on 100 parts by weight of honey,
The mixed powder includes reishi mushroom, wormwood, and slugs,
The mixed powder is
Reishi mushroom is coated with egg yolk liquid, freeze-dried reishi mushroom, sagebrush, and slugs coated with egg yolk liquid, then pulverized and powdered, and the pulverized powder is coated with a natural surface modifier,
The natural surface modifier is characterized in that it is extracted from any one natural plant of bacopa monnieri, ginseng, bellflower, deodeok, hwangchil, soybean, quince, or a combination thereof.
A honey composition comprising reishi mushroom.
상기 혼합분말은
영지버섯 100중량부에 대하여 헛개 1 내지 5 중량부, 굼벵이 0.1 내지 3 중량부를 포함하는 것을 특징으로 하는
영지버섯을 포함하는 꿀 조성물.
The method of claim 1,
The mixed powder is
Reishi mushroom, characterized in that it contains 1 to 5 parts by weight and 0.1 to 3 parts by weight of slugs based on 100 parts by weight of reishi mushroom.
A honey composition comprising reishi mushroom.
꿀 100 중량부에 대하여 혼합분말 0.1 내지 30 중량부를 혼합하는 혼합단계(S200);를 포함하며,
상기 혼합분말 제조단계(S100)는
영지버섯에 난황액을 도포하는 난황액 도포단계와
난황액이 도포된 영지버섯과 헛개, 굼벵이를 동결건조하는 동결건조단계와
동결건조된 혼합물을 분쇄하는 분말화단계와
분쇄된 분말에 천연표면개질제를 코팅하는 코팅단계를 포함하며,
상기 천연표면개질제는 바코파 몬니에리, 인삼, 도라지, 더덕, 황칠, 대두, 모과 또는 이들의 조합 중 어느 하나의 천연식물로부터 추출되는 것임을 특징으로 하는
영지버섯을 포함하는 꿀 조성물의 제조방법.
A mixed powder manufacturing step (S100) of preparing a mixed powder containing reishi mushroom, wormwood, and slugs; and
A mixing step (S200) of mixing 0.1 to 30 parts by weight of the mixed powder with respect to 100 parts by weight of honey (S200);
The mixed powder manufacturing step (S100) is
The yolk liquid application step of applying the egg yolk liquid to the reishi mushroom and
A freeze-drying step of freeze-drying reishi mushrooms, sagebrush, and slugs coated with egg yolk solution and
A pulverization step of pulverizing the freeze-dried mixture and
A coating step of coating the pulverized powder with a natural surface modifier,
The natural surface modifier is characterized in that it is extracted from any one natural plant of bacopa monnieri, ginseng, bellflower, deodeok, hwangchil, soybean, quince, or a combination thereof.
Method for producing a honey composition comprising reishi mushroom.
상기 혼합분말 제조단계(S100)는
영지버섯 100중량부에 대하여 헛개 1 내지 5 중량부, 굼벵이 0.1 내지 3 중량부를 포함하는 것을 특징으로 하는
영지버섯을 포함하는 꿀 조성물의 제조방법.
5. The method of claim 4,
The mixed powder manufacturing step (S100) is
It characterized in that it contains 1 to 5 parts by weight of hutgae and 0.1 to 3 parts by weight of slugs based on 100 parts by weight of reishi mushroom.
Method for producing a honey composition comprising reishi mushroom.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210008167A KR102313188B1 (en) | 2021-01-20 | 2021-01-20 | Honey Composition comprising Ganoderma Lucidum and Manufacturing Method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210008167A KR102313188B1 (en) | 2021-01-20 | 2021-01-20 | Honey Composition comprising Ganoderma Lucidum and Manufacturing Method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102313188B1 true KR102313188B1 (en) | 2021-10-21 |
Family
ID=78268780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210008167A KR102313188B1 (en) | 2021-01-20 | 2021-01-20 | Honey Composition comprising Ganoderma Lucidum and Manufacturing Method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102313188B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890011551A (en) * | 1988-01-08 | 1989-08-21 | 박철호 | Manufacturing method of nutrition-enhanced honey containing ganoderma lucidum |
KR20120088264A (en) * | 2011-01-31 | 2012-08-08 | 이요신 | The health food using oriental medicine and acacia honey |
KR101197679B1 (en) | 2009-12-21 | 2012-11-05 | 콩 박 | Ganoderma lucidum coffee and its related manufacturing process |
KR102056108B1 (en) * | 2019-06-12 | 2019-12-16 | 농업회사법인제주황금꽃벵이주식회사 | Composition for removing hangover and improving liver function |
KR102182076B1 (en) | 2020-02-06 | 2020-11-23 | 주식회사 에코비오스 | Culture medium composition for lactobacillus comprising mushroom extract, fermented composition thereof, and a method for preparing the same |
-
2021
- 2021-01-20 KR KR1020210008167A patent/KR102313188B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890011551A (en) * | 1988-01-08 | 1989-08-21 | 박철호 | Manufacturing method of nutrition-enhanced honey containing ganoderma lucidum |
KR101197679B1 (en) | 2009-12-21 | 2012-11-05 | 콩 박 | Ganoderma lucidum coffee and its related manufacturing process |
KR20120088264A (en) * | 2011-01-31 | 2012-08-08 | 이요신 | The health food using oriental medicine and acacia honey |
KR102056108B1 (en) * | 2019-06-12 | 2019-12-16 | 농업회사법인제주황금꽃벵이주식회사 | Composition for removing hangover and improving liver function |
KR102182076B1 (en) | 2020-02-06 | 2020-11-23 | 주식회사 에코비오스 | Culture medium composition for lactobacillus comprising mushroom extract, fermented composition thereof, and a method for preparing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
KR101486648B1 (en) | Fermented Sparassis crispa and method for preparing the same | |
KR101615199B1 (en) | Functional compositions for relieving hangovers and protecting a liver, healthy food and food additive comprising the same | |
KR100750283B1 (en) | A lotus-ice cream and he method of making it for health food | |
EP3238548B1 (en) | Method for producing raw pills of fermented minerals having functions of improving constipation and recovery from fatigue, and raw pills of fermented minerals produced thereby | |
KR20170074821A (en) | Anti-Oxidant Composition Using a Fermented Materials or an Extract of Korean Dendropanax | |
KR101914344B1 (en) | A moisturizing and anti-wrinkle cosmetic composition comprising fermented barley, fermented pear juice, fermented soybeans and fermented pomegranate extract and the method preparation of thereof | |
KR101663379B1 (en) | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
KR20110058398A (en) | The method of manufacturing a plant complex acid ferment solution and use thereof | |
KR20170082288A (en) | Methods for preparing concentrated aqueous dispersion containing red ginseng powder for taking whole red ginseng | |
KR20040063680A (en) | Functional vinegar containing diet enzyme, herb medicines and functional materials | |
KR102313188B1 (en) | Honey Composition comprising Ganoderma Lucidum and Manufacturing Method thereof | |
KR20180106383A (en) | Method of manufacturing fruits preserved in honey using fresh ginseng and Moringa | |
KR101723402B1 (en) | Method of preparing compositioni containing active ingredient of culture medium of ceriporia lacerata for prevention and improvement of diabetes, diabetic complications disease from diabetes | |
CN110607245B (en) | Lucid ganoderma cordyceps sinensis capsule and preparation method thereof | |
KR102326975B1 (en) | Production method of traditional soybean paste of low salt using shitake mushroom and Dendropanax morbifera LEV and of spread jam using this | |
KR101839435B1 (en) | Anti-obesity pharmaceutical composition and method for producing the same | |
CN107927492A (en) | A kind of probiotics composite beverage and preparation method thereof | |
KR102249711B1 (en) | Composition for enhancing skin elasticity or improving skin wrinkels comprising enzyme treated extract of leguminous plants cultured root | |
KR102085713B1 (en) | Method for producing vinegar foaming tablet for diet | |
CN108210526B (en) | Sparassis crispa extract anti-aging preparation and preparation method thereof | |
KR101395412B1 (en) | The method of preparing natural drink extract for health | |
KR20180013306A (en) | Method for manufacturing honey comprising cinnamon | |
KR20170014238A (en) | Fermented black garlic comprising kochujang and Preparation Method Thereof | |
KR20090098254A (en) | Method for producing artemisia extract by fermentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
GRNT | Written decision to grant |